Related references
Note: Only part of the references are listed.Is the Concurrent Use of Sorafenib and External Radiotherapy Feasible for Advanced Hepatocellular Carcinoma? A Meta-Analysis
Chai Hong Rim et al.
CANCERS (2021)
Safety and efficacy of drug-eluting bead transarterial chemoembolization with CalliSpheres® microsphere for hepatocellular carcinoma with portal vein tumor thrombus: a preliminary study
Tan-Yang Zhou et al.
JOURNAL OF CANCER (2021)
Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis
Jungang Hu et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2020)
Molecular therapies for HCC: Looking outside the box
Sandrine Faivre et al.
JOURNAL OF HEPATOLOGY (2020)
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
Masatoshi Kudo et al.
GUT (2020)
Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma
Zhenwei Peng et al.
RADIOLOGY (2019)
Sorafenib with Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort Study
Victor C. Kok et al.
CANCERS (2019)
An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study
Xiu-Ping Zhang et al.
HEPATOLOGY (2019)
Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis
Laura Kulik et al.
HEPATOLOGY (2018)
90Y Radioembolization for Locally Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Long-Term Outcomes in a 185-Patient Cohort
Nadine Abouchaleh et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Comparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: A meta-analysis and systematic review
Chai Hong Rim et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
Jong Hwan Choi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radlotrequency Ablation
Zhenwei Peng et al.
RADIOLOGY (2018)
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Vogel et al.
ANNALS OF ONCOLOGY (2018)
Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies
Po-Hong Liu et al.
SEMINARS IN LIVER DISEASE (2018)
Transarterial chemoembolization combined with computed tomography-guided 125iodine implantation enhances survival in hepatocellular carcinoma patients with portal vein tumor thrombus
Hong Tao Hu et al.
ONCOTARGET (2017)
An adverse event capture and management system for cancer studies
Alex Lencioni et al.
BMC BIOINFORMATICS (2015)
Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial
MinJie Yang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Treatment with Transarterial Chemoembolization Combined with Sorafenib-A Retrospective Controlled Study
Kangshun Zhu et al.
RADIOLOGY (2014)
Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis
Tong-Chun Xue et al.
BMC GASTROENTEROLOGY (2013)
Practical Effect of Sorafenib Monotherapy on Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis
Soung Won Jeong et al.
GUT AND LIVER (2013)
Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis
Do Seon Song et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Chemoembolization for Hepatocellular Carcinoma: Multivariate Analysis of Predicting Factors for Tumor Response and Survival in a 362-Patient Cohort
Hong Tao Hu et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2011)
Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
Alejandro Forner et al.
SEMINARS IN LIVER DISEASE (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
Share Paper
